Cure My Disease

Don't miss your cure!

 Log in / Sign up

Breakfast or not? study tests Food's impact on new drug formulation

NCT ID NCT06996184

Completed Knowledge-focused Sponsor: CSL Behring Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed Phase 1 trial studied 28 healthy adults to see how food changes the absorption of a new prolonged-release version of vamifeport, an experimental drug. Participants took a single dose of the drug either with or without food, and researchers measured drug levels in the blood. The goal was to understand if food affects how the drug is processed, which will guide future dosing instructions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Vamifeport (prolonged-release formulation)
What this could lead to
If successful, this could help determine the best way to take vamifeport (with or without food) for future studies in patients.
What could go wrong
This is a very early, small study in healthy volunteers, not patients. It only looks at drug levels and safety, not whether the drug works for any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEERS

Contacts and locations

Locations

  • Investigator Site 82600083

    Leeds, West Yorkshire, LS11 9E, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.